Aquatic Capital Management LLC Verona Pharma PLC Transaction History
Aquatic Capital Management LLC
- $3.86 Billion
- Q1 2025
A detailed history of Aquatic Capital Management LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Aquatic Capital Management LLC holds 63,019 shares of VRNA stock, worth $5.9 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
63,019
Previous 20,787
203.17%
Holding current value
$5.9 Million
Previous $965,000
314.61%
% of portfolio
0.1%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding VRNA
# of Institutions
291Shares Held
74.3MCall Options Held
933KPut Options Held
1.98M-
Perceptive Advisors LLC New York, NY6.56MShares$614 Million17.44% of portfolio
-
Janus Henderson Group PLC London, X05.52MShares$516 Million0.2% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y93.92MShares$367 Million17.31% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.46MShares$324 Million13.82% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.89MShares$271 Million3.9% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $5.71B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...